4.5 Article

Effect of PEGylation on Drug Entry into Lipid Bilayer

Journal

JOURNAL OF PHYSICAL CHEMISTRY B
Volume 118, Issue 1, Pages 144-151

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jp4105745

Keywords

-

Funding

  1. EU European Regional Development Fund, PolyMed [TEAM/2008-2/6]
  2. Academy of Finland
  3. European Research Council (Advanced Grant project CROWDED-PRO-LIPIDS)

Ask authors/readers for more resources

Poly(ethylene glycol) (PEG) is a polymer commonly used for functionalization of drug molecules to increase their bloodstream lifetime, hence efficacy. However, the interactions between the PEGylated drugs and biomembranes are not clearly understood. In this study, we employed atomic-scale molecular dynamics (MD) simulations to consider the behavior of two drug molecules functionalized with PEG (tetraphenylporphyrin used in cancer phototherapy and biochanin A belonging to the isoflavone family) in the presence of a lipid bilayer. The commonly held view is that functionalization of a drug molecule with a polymer acts as an entropic barrier, inhibiting the penetration of the drug molecule through a cell membrane. Our results indicate that in the bloodstream there is an additional source of electrostatic repulsive interactions between the PEGylated drugs and the lipid bilayer. Both the PEG chain and lipids can bind Na+ ions, thus effectively becoming positively charged molecules. This leads to an extra repulsive effect resulting from the presence of salt in the bloodstream. Thus, our study sheds further light on the role of PEG in drug delivery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available